• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

索托斯综合征中的 NSD1 突变。

NSD1 mutations in Sotos syndrome.

作者信息

Faravelli Francesca

机构信息

Department of Human Genetics of Galliera Hospital, Genoa, Italy.

出版信息

Am J Med Genet C Semin Med Genet. 2005 Aug 15;137C(1):24-31. doi: 10.1002/ajmg.c.30061.

DOI:10.1002/ajmg.c.30061
PMID:16010675
Abstract

Sotos syndrome is a genetic disorder characterized by a typical facial appearance, macrocephaly, accelerated growth, developmental delay, and a variable range of associated abnormalities. The NSD1 gene was recently found to be responsible for Sotos syndrome, and more than 150 patients with NSD1 alterations have been identified. A significant ethnic difference is found in the prevalence of different types of mutation, with a high percentage of microdeletions identified in Japanese Sotos syndrome patients and with intragenic mutations in most non-Japanese patients. NSD1 aberrations are rather specific for Sotos syndrome, but have also been detected in patients lacking one or more major criteria of the disorder, namely overgrowth, macrocephaly, and advanced bone age. Thus, new diagnostic criteria should be considered. Studies have reported different frequencies of mutations versus non-mutations in Sotos syndrome, thus indicating allelic or locus hetereogeneity. Although some authors have suggested genotype/phenotype correlations, further studies are needed.

摘要

索托斯综合征是一种遗传性疾病,其特征为典型的面部外观、巨头畸形、生长加速、发育迟缓以及一系列相关的异常表现。最近发现NSD1基因与索托斯综合征有关,已鉴定出150多名NSD1基因改变的患者。在不同类型突变的患病率上发现了显著的种族差异,日本索托斯综合征患者中微缺失的比例较高,而大多数非日本患者中存在基因内突变。NSD1畸变对索托斯综合征具有相当的特异性,但在缺乏该疾病一项或多项主要标准(即生长过速、巨头畸形和骨龄提前)的患者中也有发现。因此,应考虑新的诊断标准。研究报告了索托斯综合征中突变与非突变的不同频率,从而表明存在等位基因或位点异质性。尽管一些作者提出了基因型/表型相关性,但仍需要进一步研究。

相似文献

1
NSD1 mutations in Sotos syndrome.索托斯综合征中的 NSD1 突变。
Am J Med Genet C Semin Med Genet. 2005 Aug 15;137C(1):24-31. doi: 10.1002/ajmg.c.30061.
2
Spectrum of NSD1 gene mutations in southern Chinese patients with Sotos syndrome.中国南方索托斯综合征患者 NSD1 基因突变谱
Chin Med J (Engl). 2005 Sep 20;118(18):1499-506.
3
Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypes.NSD1基因的突变是导致索托斯综合征的原因,但在其他过度生长表型中并不常见。
Eur J Hum Genet. 2003 Nov;11(11):858-65. doi: 10.1038/sj.ejhg.5201050.
4
Heterogeneity of NSD1 alterations in 116 patients with Sotos syndrome.116例索托斯综合征患者中NSD1改变的异质性。
Hum Mutat. 2007 Nov;28(11):1098-107. doi: 10.1002/humu.20568.
5
MLPA analysis in 30 Sotos syndrome patients revealed one total NSD1 deletion and two partial deletions not previously reported.对30例索托斯综合征患者进行的多重连接依赖探针扩增(MLPA)分析显示,存在1例NSD1基因完全缺失和2例此前未报道的部分缺失。
Eur J Med Genet. 2009 Sep-Oct;52(5):333-6. doi: 10.1016/j.ejmg.2009.07.001. Epub 2009 Jul 9.
6
Three novel mutations in greek sotos patients with rare clinical manifestations.希腊患有罕见临床表现的索托斯综合征患者中的三种新突变。
Horm Res. 2009 Jan;71(1):45-51. doi: 10.1159/000173741. Epub 2008 Nov 27.
7
Leukocyte cDNA analysis of NSD1 derived from confirmed Sotos syndrome patients.对确诊的索托斯综合征患者来源的NSD1进行白细胞cDNA分析。
Ann Hum Genet. 2007 Nov;71(Pt 6):713-8. doi: 10.1111/j.1469-1809.2007.00376.x. Epub 2007 Jun 11.
8
Spectrum of NSD1 mutations in Sotos and Weaver syndromes.索托斯综合征和韦弗综合征中 NSD1 突变谱。
J Med Genet. 2003 Jun;40(6):436-40. doi: 10.1136/jmg.40.6.436.
9
Two cases of Sotos syndrome with novel mutations of the NSD1 gene.两例伴有NSD1基因新突变的索托斯综合征病例。
Genet Couns. 2010;21(1):53-9.
10
dHPLC screening of the NSD1 gene identifies nine novel mutations--summary of the first 100 Sotos syndrome mutations.NSD1基因的变性高效液相色谱筛查鉴定出9个新突变——前100例索托斯综合征突变总结。
Ann Hum Genet. 2005 Mar;69(Pt 2):222-6. doi: 10.1046/j.1529-8817.2004.00150.x.

引用本文的文献

1
SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylation.SETD2功能缺失使细胞对NSD1介导的H3K36甲基化的表观遗传靶向作用特别敏感。
Genome Biol. 2025 Feb 5;26(1):22. doi: 10.1186/s13059-025-03483-z.
2
The role of histone methyltransferases in neurocognitive disorders associated with brain size abnormalities.组蛋白甲基转移酶在与脑容量异常相关的神经认知障碍中的作用。
Front Neurosci. 2023 Feb 10;17:989109. doi: 10.3389/fnins.2023.989109. eCollection 2023.
3
Upfront Screening by Quantitative Real-Time PCR Assay Identifies NUP98::NSD1 Fusion Transcript in Indian AML Patients.
通过定量实时聚合酶链反应检测进行的前期筛查在印度急性髓系白血病患者中鉴定出NUP98::NSD1融合转录本
Diagnostics (Basel). 2022 Dec 1;12(12):3001. doi: 10.3390/diagnostics12123001.
4
H3K36 methyltransferase NSD1 is essential for normal B1 and B2 cell development and germinal center formation.H3K36 甲基转移酶 NSD1 对于正常 B1 和 B2 细胞发育以及生发中心形成是必需的。
Front Immunol. 2022 Nov 30;13:959021. doi: 10.3389/fimmu.2022.959021. eCollection 2022.
5
Understanding histone H3 lysine 36 methylation and its deregulation in disease.理解组蛋白 H3 赖氨酸 36 位甲基化及其在疾病中的失调。
Cell Mol Life Sci. 2019 Aug;76(15):2899-2916. doi: 10.1007/s00018-019-03144-y. Epub 2019 May 30.
6
Steric Clash in the SET Domain of Histone Methyltransferase NSD1 as a Cause of Sotos Syndrome and Its Genetic Heterogeneity in a Brazilian Cohort.组蛋白甲基转移酶NSD1的SET结构域中的空间冲突作为巴西队列中索托斯综合征的病因及其遗传异质性
Genes (Basel). 2016 Nov 9;7(11):96. doi: 10.3390/genes7110096.
7
Pan-cancer stratification of solid human epithelial tumors and cancer cell lines reveals commonalities and tissue-specific features of the CpG island methylator phenotype.实体人类上皮肿瘤和癌细胞系的泛癌分层揭示了CpG岛甲基化表型的共性和组织特异性特征。
Epigenetics Chromatin. 2015 Apr 17;8:14. doi: 10.1186/s13072-015-0007-7. eCollection 2015.
8
Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.组蛋白甲基转移酶MMSET/NSD2通过H3K36和H3K27甲基化的整体和局部变化改变EZH2结合并重新编程骨髓瘤表观基因组。
PLoS Genet. 2014 Sep 4;10(9):e1004566. doi: 10.1371/journal.pgen.1004566. eCollection 2014 Sep.
9
The methyltransferase NSD3 has chromatin-binding motifs, PHD5-C5HCH, that are distinct from other NSD (nuclear receptor SET domain) family members in their histone H3 recognition.甲基转移酶 NSD3 具有染色质结合基序 PHD5-C5HCH,与其他 NSD(核受体 SET 结构域)家族成员在识别组蛋白 H3 方面有所不同。
J Biol Chem. 2013 Feb 15;288(7):4692-703. doi: 10.1074/jbc.M112.426148. Epub 2012 Dec 26.
10
Emerging epigenetic targets and therapies in cancer medicine.癌症医学中新兴的表观遗传学靶点和治疗方法。
Cancer Discov. 2012 May;2(5):405-13. doi: 10.1158/2159-8290.CD-12-0076. Epub 2012 Apr 23.